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Abstract: The common marmoset (Callithrix jacchus) has attracted considerable attention, especially
in the biomedical science and neuroscience research fields, because of its potential to recapitulate
the complex and multidimensional phenotypes of human diseases, and several neurodegenerative
transgenic models have been reported. However, there remain several issues as (i) it takes years
to generate late-onset disease models, and (ii) the onset age and severity of phenotypes can vary
among individuals due to differences in genetic background. In the present study, we established
an efficient and rapid direct neuronal induction method (induced neurons; iNs) from embryonic
and adult marmoset fibroblasts to investigate cellular-level phenotypes in the marmoset brain
in vitro. We overexpressed reprogramming effectors, i.e., microRNA-9/9*, microRNA-124, and
Achaete-Scute family bHLH transcription factor 1, in fibroblasts with a small molecule cocktail that
facilitates neuronal induction. The resultant iNs from embryonic and adult marmoset fibroblasts
showed neuronal characteristics within two weeks, including neuron-specific gene expression and
spontaneous neuronal activity. As directly reprogrammed neurons have been shown to model
neurodegenerative disorders, the neuronal reprogramming of marmoset fibroblasts may offer new
tools for investigating neurological phenotypes associated with disease progression in non-human
primate neurological disease models.
Keywords: direct reprogramming; induced neuron (iN); common marmoset; microRNA-9/9*;
microRNA-124; ASCL1
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1. Introduction
The common marmoset (Callithrix jacchus), a small and fecund non-human primate,
has attracted attention in the field of neuroscience research due to its anatomical and
behavioral similarities to humans. Especially, the availability of transgenic techniques has
allowed genetically modified marmosets to be developed as human disease models [1–4].
Although these studies have proven the significance of marmoset models, the following
challenges remain: (i) marmoset models for late-onset diseases require several years to
develop disease phenotypes because of their long lifespan (16–21 years [5]), and (ii) the
onset age and severity of phenotypes can vary among individuals due to differences in
genetic background, making it difficult to predict them before onset. Direct brain tissue
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sampling from live marmosets is highly invasive and interferes with behavioral analysis. To
overcome these problems, a low-invasive and non-intrusive evaluation method is required.
Somatic cells in a terminally differentiated state can be reprogrammed into pluripotent
stem cells by the overexpression of defined transcription factors, suggesting that artificial
reversion of cell fate is feasible [6]. Previous studies have reported that several transcription
factors can directly convert mouse and human somatic cells into various types of cells,
such as cardiomyocytes [7,8], hepatocytes [9,10], neural stem cells [11], and neurons [12,13].
Among the reprogramming techniques utilizing induced pluripotent stem cells, the direct
conversion of somatic cells into neurons (induced neurons; iNs) has advantages for in vitro
disease modeling of neurodegenerative diseases in terms of its rapid and tractable induction. The iN method also permits neuron-induction while retaining age-related epigenetic
signatures [14]. Thus, we focused on the direct neuronal reprogramming of marmoset
somatic cells.
We previously reported a direct neuronal induction method from embryonic marmoset
fibroblasts by overexpressing four transcription factors: POU class 3 homeobox 2, AchaeteScute family bHLH transcription factor 1 (ASCL1), myelin transcription factor 1-like, and
neuronal differentiation 1 [15]. However, there are serious problems associated with this
method, such as the low-induction efficiency (~1%), insufficient maturation, and inability
to induce neurons from postnatal marmoset fibroblasts, which may impose limitations on
its applicability for the in vitro analysis of genetically modified marmosets.
Recent studies on human fibroblasts have revealed a new approach for the direct
conversion of fibroblasts to neurons using microRNA-9/9* and microRNA-124 (miR-9/9*124) [16,17], which inhibit the neuronal gene-specific repressor REST complex and promote
neuronal differentiation and maturation [18]. Furthermore, ASCL1, a key transcription
factor of neuronal specification in early development [19] can also directly induce the
conversion of fibroblasts into neurons. In the present study, we demonstrated that the
exogenous expression of miR-9/9*-124 and ASCL1 could induce embryonic and adult
marmoset fibroblasts to develop into neuronal cells. The iNs generated in this study
showed neuronal gene expression and spontaneous neuronal activity, as measured by
calcium imaging. In addition, the conversion of marmoset somatic cells into neuron-like
cells occurred within only two weeks, in contrast to the extended culture time of months to
differentiate induced pluripotent stem cells into neurons. Importantly, the iN conversion
method could also be extended to postnatal fibroblasts, which is critical for the in vitro
evaluation of genetically modified marmoset phenotypes without surgical invasion in the
fetal period.
2. Materials and Methods
2.1. Animals and Ethical Statements
Common marmoset tissue samples were collected at the RIKEN Center for Brain Science. The animal experiments in this project were approved by the Animal Experimental
Committee of RIKEN (approval number H29-2-243(5)), and were performed in accordance
with institutional guidelines for the use of laboratory animals at RIKEN, which are consistent with the Guidelines for the Proper Conduct of Animal Experiments by the Science
Council of Japan (2006). Animal care was conducted in accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals (National Research Council,
2011). The two adult marmosets used in the current study were 2 years and 4–5 months old
when their ear skin-derived fibroblasts were collected. These adult marmosets were born
from independent parents. For embryonic fibroblasts, dorsal skin-derived fibroblasts from
two littermate marmosets at embryonic day 95 were used. Information on the age, sex, and
individual identification number of each marmoset is listed in Supplementary Table S1.
2.2. Vectors
The piggyBac transposon vector (pCMV-hyPBase) was kindly provided by Drs. Kosuke Yusa and Allan Bradley (Wellcome Trust Sanger Institute). pPB-tetpA (hBCL2-miR-
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9/9*-124)-iRPT was obtained with the Gateway LR reaction using the Gateway LR Clonase
II Enzyme mix (Thermo Fisher Scientific, Waltham, MA, USA), pENTR-hBCL2 and pENTRR2-mmu-miR-9/9*-124-L4 (both were kindly provided by Dr. Takefumi Sone, Keio University), and pPB-tetpA(R1R4)-iRPT. To generate pPB-tetpA(R1R4)-iRPT, the attR2 site of
pPB-tetpA-iRPT [20] was replaced with an attR4 site by seamless cloning using a GeneArt Seamless PLUS Cloning and Assembly Kit (Thermo Fisher Scientific) and an attR4
fragment amplified from pUC-DEST-R3R4(R) [21] following EcoRI and SalI digestion.
The CSIV-TRE-ASCL1 lentiviral vector was constructed by the Gateway LR reaction of
CSIV-TRE-DEST (kindly provided by Dr. Takefumi Sone) and pENTR-hASCL1 (kindly
provided by Drs. Yuhki Nakatake and Minoru Ko, Keio University). We have deposited
pPB-tetpA(R1R4)-iRPT (#154882), pPB-tetpA(hBCL2-miR-9/9*-124)-iRPT (#154881), and
CSIV-TRE-ASCL1 (#154883) into Addgene (https://www.addgene.org). For lentivirus production, pCAG-HIVgp and pCMV-VSV-G-RSV-Rev were kindly provided by Dr. Hiroyuki
Miyoshi (Keio University).
2.3. Lentivirus Production
The TRE-ASCL1 lentivirus was produced as described previously [15]. In brief,
3.0 µg pCAG-HIVgp, 3.0 µg pCMV-VSV-G-RSV-Rev, and 6.0 µg CSIV-TRE-ASCL1 were
transfected into HEK293T cells by polyethyleneimine in a 10-cm sub-confluent dish in
Dulbecco’s modified Eagle’s medium with high glucose (DMEM; Thermo Fisher Scientific)
supplemented with 10% inactivated fetal bovine serum (FBS; Sigma Aldrich, St. Louis,
MO, USA) and 1% penicillin/streptomycin solution (Nacalai Tesque, Kyoto, Japan). The
following day, the medium was replaced with 10% FBS DMEM containing 10 µM forskolin
(Sigma Aldrich). At 2 days after medium change, the lentivirus-containing supernatant
was collected and passed through a 0.2-µm filter. The filtrated supernatant was ultracentrifuged at 25,000 rpm for 2 h at 4 ◦ C. The ultracentrifuged supernatant was additionally
concentrated by ultrafiltration using Amicon Ultra 0.5-mL filters (Millipore, Burlington,
MA, USA).
2.4. Cell Culture and Transfection
Fibroblasts were cultured in fibroblast medium consisting of DMEM supplemented
with 10% inactivated FBS and 1% penicillin/streptomycin solution. The day before transfection, the cells were seeded on a gelatin-coated 6-well plate (Greiner, Monroe, NC, USA) and
incubated overnight at 37 ◦ C in 5% CO2 . For transfection, 1.0 µg DNA vectors, consisting
of 0.8 µg pPB-tetpA(hBCL2-miR-9/9*-124)-iRPT and 0.2 µg pCMV-hyPBase, lipofectamineLTX PLUS reagent (1 µL; Thermo Fisher Scientific), and LTX reagent (2.5 µL; Thermo
Fisher Scientific) were diluted in 200 µL Opti-MEM (Thermo Fisher Scientific) and added
to the sub-confluent cells in each well of a 6-well plate. The following day, fresh fibroblast
medium was added. At 3 days after transfection, puromycin selection (5 µg/mL) was
started and conducted for 1–2 weeks. After selection, the cells were infected with the
TRE-ASCL1 lentivirus.
2.5. Neuronal Induction
Fibroblasts transfected with pPB-tetpA(hBCL2-miR-9/9*-124)-iRPT and the TREASCL1 lentivirus were used for neuronal conversion. On the first day of induction (post
induction day [PID] 0), 1.0 × 105 cells were seeded in each well of a gelatin-coated 12-well
plate (Iwaki, Shizuoka, Japan) and cultured in fibroblast medium containing 2 µg/mL
doxycycline (Dox; FUJIFILM Wako Pure Chemical, Osaka, Japan). On PID 2, the cells
were cultured in fresh fibroblast medium containing Dox. On PID 4, a 50-µL cell drop
consisting of fibroblast medium and 5.0 × 104 cells was added to each well of a polyL-ornithine/laminin/fibronectin-coated plate, and cultured in fibroblast medium after
the cells attached. The following day (PID 5), the medium was switched to a neuronal
reprogramming medium composed of a 1:1 mixture of Neurobasal medium (Thermo Fisher
Scientific) and DMEM/F-12 (FUJIFIM Wako Pure Chemical) supplemented with 1% N2
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supplement (Thermo Fisher Scientific), 2% B27 supplement (Thermo Fisher Scientific), 1%
non-essential amino acid solution (Sigma Aldrich), 1 mM L-glutamine (Nacalai Tesque),
200 µM dbcAMP (Sigma Aldrich), 10 µM forskolin, 10 µM Y-27632 (FUJIFILM Wako Pure
Chemical), 3 µM CHIR99021 (Axon Medchem, Groningen, Nederland), 1 µM PD-0325901
(FUJIFILM Wako Pure Chemical), 0.5 µM A83-01 (Santa Cruz, Dallas, TX, USA), 10 ng/mL
recombinant human leukemia inhibitory factor (Oriental Yeast, Tokyo, Japan), 1 mM valproic acid (FUJIFILM Wako Pure Chemical), 10 ng/mL brain-derived neurotrophic factor
(Peprotech, Rocky Hill, NJ, USA), 10 ng/mL glial cell line-derived neurotrophic factor (Peprotech), 10 ng/mL neurotrophin-3 (Peprotech), 200 µM ascorbic acid (Sigma Aldrich), and
1 µM retinoic acid (Sigma Aldrich), supplemented with Dox and penicillin/streptomycin.
The medium was changed every 4 days.
2.6. Immunocytochemistry
The cells were fixed in 4% paraformaldehyde for 15 min and permeabilized with
0.3% Triton-X in phosphate-buffered saline (PBS) for 10 min. The cells were blocked with
5% bovine serum albumin (Nacalai Tesque) in PBS for 1 h and incubated overnight at
4 ◦ C with the following primary antibodies: rabbit anti-class III β-tubulin (βIII-tubulin;
Abcam; ab18207; 1:500), mouse anti-βIII-tubulin (Sigma Aldrich; T8660; 1:500), mouse
anti-microtubule associated protein 2 (MAP2; Sigma Aldrich; M4403; 1:500), mouse antiNeuN (Merck Millipore; MAB377; 1:500), guinea pig anti-synaptophysin (SYP) 1 (Synaptic
Systems; 101 004; 1:500), rabbit anti-postsynaptic density protein 95 (PSD95; Thermo Fisher
Scientific; 51-6900; 1:500), rabbit anti-vesicular glutamate transporter 1 (Synaptic Systems;
135 303; 1:500), and mouse anti-ASCL1 (BD Pharmingen; 556604; 1:500). The following day,
the cells were washed with PBS and incubated with secondary antibodies conjugated with
Alexa Fluor 488, 555, or 647 (Thermo Fisher Scientific; 1:1000) for 1 h at room temperature.
The nuclei were stained with Hoechst 33342 (Thermo Fisher Scientific; 1:2000). When
immunostaining with Alexa Fluor 647, the cells were heat-treated at 105 ◦ C for 5 min
in Target Retrieval Solution (Agilent, Santa Clara, CA, USA) after fixation to extinguish
iRFP fluorescence. Images were observed under the LSM 700 confocal system (Carl Zeiss,
Oberkochen, Germany).
2.7. Calcium Imaging Analysis
The cells were washed twice with PBS and incubated in the neuronal reprogramming
medium containing Fluo-8 (AAT Bioquest, Sunnyvale, CA, USA; 1 µM) and Hoechst 33342
(1:1000) for 20 min at 37 ◦ C in 5% CO2 . After incubation, the cells were washed twice
with PBS and fed with neuronal reprogramming medium. For tetrodotoxin treatment, the
reagent was dropped into the culture wells to reach a final concentration of 5 µM. Movies
were captured at 20 frames/s using an IX83 inverted microscope (Olympus, Tokyo, Japan)
equipped with an electron multiplying CCD camera (Hamamatsu Photonics, Hamamatsu,
Shizuoka, Japan) and pE-4000 LED illumination system (CoolLED, Andover, UK). Imaging
data analysis was performed using the miniscope 1-photon-based calcium imaging signal
extraction pipeline [22], which contains modules for background subtraction, movement
correction, and neural signal extraction. After that, neuron locations and traces were
extracted, and we identified the rising phase of each calcium transient as the calcium event
(peak ∆F/F0 > 0.5 standard deviations of baseline fluctuations). The start of this rising
phase is detected when the 1st derivative of ∆F/F0 rises above 0 and continues to increase
above 2 standard deviations of baseline fluctuations.
2.8. Quantitative RT-PCR
RNA was isolated using an RNeasy Mini Kit (QIAGEN, Hilden, Germany) according
to the manufacturer’s protocol. Total RNA (1.0 µg) was reverse-transcribed in ReverTra Ace
qPCR RT master mix (Toyobo, Osaka, Japan). The resultant cDNAs were diluted to 4 ng/µL
in nuclease-free water. Quantitative RT-PCR was performed using TB Green Premix Ex
Taq II (TaKaRa Bio, Kusatsu, Shiga, Japan) on the ViiA 7 Real-Time PCR System (Thermo
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Fisher Scientific) according to the manufacturer’s instructions. The sequences of primers
used in this study are listed in Supplementary Table S2. Glyceraldehyde 3-phosphate
dehydrogenase expression was used for normalization. Four-year-old marmoset frontal
cortex (brain tissue) was used for control samples.
2.9. Tissue Preparation
The marmoset brain tissue used for control sample was obtained from a four-year-old
male marmoset. To obtain brain tissue, the marmoset was anesthetized with ketamine
(10 mg/kg) and pentobarbital (80 mg/kg) by intramuscular injection. Under deep anesthesia, the marmosets were euthanized by exsanguination and perfused intracardially with
0.1 M phosphate-buffered saline (PBS, pH 7.6). After 10 min of perfusion, the frontal cortex
was removed, immediately frozen in liquid nitrogen, and stored at −80 ◦ C until RNA
extraction as described above.
2.10. Transcriptomic Analysis
Extraction of total cellular RNA was performed as described above. Poly(A)+ RNA
was selected and converted to a library of cDNA fragments (mean length: 350 bp) with
adaptors attached to both ends for sequencing using a KAPA mRNA Capture Kit (KK8440;
Kapa Biosystems, Wilmington, MA, USA), KAPA RNA HyperPrep Kit (KK8542; Kapa
Biosystems), KAPA Pure Beads (KK8543; Kapa Biosystems), and SeqCap Adapter Kit
A (Roche, Basel, Switzerland) according to the manufacturers’ instructions. The cDNA
libraries were quantified using a KAPA Library Quantification Kits (KK4828; Kapa Biosystems), followed by sequencing using an Illumina HiSeq X to obtain 150-nucleotide sequences (paired-end). RNA-sequencing (seq) data (fastq file format) were quality checked,
and low-quality reads (score < 30), adapter sequences, and overrepresented sequences such
as poly-A chains were trimmed using Trim Galore! (ver.0.4.0). The remaining reads were
mapped to the C. jacchus genome (cj3.2.1.86) using STAR (ver.2.5.3a) [23], and the output file
(BAM file format) was summarized using featureCounts [24] (1.5.2). The summarized data
were processed using DESeq2 [25] to estimate their size factors, followed by the removal
of reads not expressed in any of the samples. We identified differentially expressed genes
with a cutoff of 0.01 for Benjamini-Hochberg-adjusted p-values and a cutoff of 5 for the
fold-change ratio. Principal component analysis was performed using variance-stabilizing
transformation of the estimated counts. Enrichment analysis using gene ontology was
performed using clusterProfiler [26]. Heatmaps of gene expression were drawn using the
row-wise z-scores of the variance-stabilizing transformation-normalized expression values
of each gene. We have deposited the raw and processed RNA-seq data obtained in this
study into the Gene Expression Omnibus (accession number: GSE152433). For the analysis,
we also included deposited data (GSE152264) obtained in our previous study [20].
2.11. Statistical Analysis
All data are expressed as the mean ± standard error of the mean. Statistical analyses
were performed using RStudio. mRNA expression levels in each group were compared
statistically with one-way analysis of variance, followed by a post hoc Tukey’s test.
3. Results
3.1. Direct Neuronal Induction of Adult and Embryonic Somatic Fibroblasts Derived from Marmosets
We previously reported a direct neuronal induction method using marmoset embryonic skin fibroblasts by lentiviral overexpression of four transcription factors [15], but
with low induction efficiency (~1%) and inapplicability to adult marmoset fibroblasts.
Accordingly, the aim of the present study was to devise a novel neuronal induction method
that is efficient and applicable to adult marmoset fibroblasts. For that purpose, we focused
on neuron-specific microRNAs (miR-9/9*-124) that have been demonstrated to induce
the efficient neuronal conversion of human fibroblasts [16,17]. Moreover, we tested the
combined overexpression of the neuronal transcription factor ASCL1, a pioneer transcrip-
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tion factor for the direct neuronal conversion of mouse and human iNs [27,28], with these
microRNAs for efficient induction.
We first constructed a piggyBac transposition-based vector [29] encoding miR-9/9*124 and the anti-apoptotic factor human B-cell lymphoma 2 (BCL2) under Dox-dependent
transcriptional control by the tetracycline response element (TRE). In addition to its role in
apoptosis inhibition, BCL2 promotes the neuronal conversion of somatic cells by enhancing
mitochondrial oxidative metabolism [30]. The piggyBac vector also carried infrared fluorescent protein (iRFP), a drug selection marker (puromycin N-acetyl-transferase gene), and
reverse tetracycline transactivator under the control of the elongation factor 1α promoter
in the opposite direction to miR-9/9*-124 (Figure 1A, left). Each gene was connected by
2A peptides. We also constructed a lentiviral vector carrying ASCL1 under the control of
the TRE (Figure 1A, right) for its combined overexpression with miR-9/9*-124 in a Doxdependent manner. Both vectors were co-transfected into marmoset fibroblasts, followed
by drug selection using puromycin for 1–2 weeks. Successful transduction was confirmed
by expression of the iRFP reporter in almost all cells (Supplementary Figure S1). After drug
selection, each fibroblast cell line derived from two embryonic and adult marmosets (Supplementary Table S1) was induced to express miR-9/9*-124 and ASCL1 by Dox treatment
from PID 0, as shown in the timetable in Figure 1B. These fibroblast cells were re-plated on
a dish with neuronal cell-optimized coating at PID 4. The fibroblast medium was changed
to neuronal reprogramming medium at PID 5, and the fibroblasts then underwent a morphological change into a spherical structure within a few hours. Moreover, the spherical
cells extended neurite-like projections and changed to a neuron-like morphology at two
weeks after the start of induction (Figure 1C). There were no morphological differences
between the neuron-like cells derived from embryonic and adult marmoset fibroblasts.
These results showed that miR-9/9*-124 and ASCL1 overexpression can convert adult and
embryonic marmoset fibroblasts into neuron-like cells rapidly.
3.2. Neuron-Like Cells Express a Subset of Pan-Neuronal Markers at the Protein Level
To characterize the neuron-like cells, we performed immunocytochemistry using
antibodies for pan-neuronal markers. We found that the neuron-like cells derived from embryonic and adult marmoset fibroblasts expressed pan-neuronal cytoskeletal markers, such
as neuron-specific βIII-tubulin and MAP2, in the neurite-like projections and cell bodies at
PID 15 (Figure 2A). Furthermore, the expression of the mature neuronal nuclear marker
NeuN was also detected in the neuron-like cells (Figure 2A). These neuronal markers were
not expressed in the original fibroblasts (Supplementary Figure S2A). Quantitatively, ~80%
of the neuron-like cells were positive for βIII-tubulin and a similar proportion of cells were
positive for MAP2 (Figure 2B). In addition, ~60% of the neuron-like cells derived from
adult marmoset fibroblasts and ~80% of the cells derived from embryonic fibroblasts were
positive for NeuN (Figure 2B). The expression of the synaptic markers SYP and PSD95
was also detected in the embryonic and adult neuron-like cells (Figure 2C). Inspection of
high-magnification images revealed the appearance of immuno-positive puncta along the
periphery of the neurite-like structures (Figure 2D). The colocalization of pre- and postsynaptic puncta was sometimes observed in the neuron-like cells derived from embryonic
marmoset fibroblasts. A comparison of the number of SYP- and PSD95-positive puncta
per mm2 showed a higher density of synaptic puncta in the embryonic neuron-like cells
than in the adult neuron-like cells (Figure 2E). Some of the neuron-like cells were positive
for the excitatory synaptic marker vesicular glutamate transporter 1, especially in the
embryonic fibroblast-derived neuron-like cells with a high frequency (Figure 2F). We found
that the ASCL1-expressing neuron-like cells were positive for βIII-tubulin (Supplementary
Figure S2B, arrow), whereas the ASCL1-negative cells did not express it (arrowhead),
suggesting a contribution of ASCL1 to neuronal induction. These results demonstrated
that the combined overexpression of miR-9/9*-124 with ASCL1 can induce the expression
of neuronal proteins.
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Figure 1. Neuronal induction of marmoset fibroblasts by overexpressing microRNA-9/9* and microRNA-124 (miR-9/9*-124)
Figure 1.family
Neuronal
of factor
marmoset
fibroblasts
byPiggyBac
overexpressing
microRNA-9/9*
and(1) infrared
and Achaete-Scute
bHLHinduction
transcription
1 (ASCL1).
(A) Left:
transposon
vector containing
microRNA-124
(miR-9/9*-124)
and
Achaete-Scute
family
bHLH
transcription
factor
1
(ASCL1).
R
fluorescent protein (iRFP), puromycin resistance (Puro ), and reverse tetracycline transactivator (rtTA) under(A)
the control of
Left: factor
PiggyBac
transposon
vector
(1) infrared
fluorescent
(iRFP), puromycin
the elongation
1α (EF1α)
promoter,
and containing
(2) human B-cell
lymphoma
2 (BCL2) protein
and miR-9/9*-124
under the control of
R), and reverse tetracycline transactivator (rtTA) under the control of the elongation
resistance
(Puroelement
the tetracycline
response
(TRE) promoter. Right: Lentiviral vector containing ASCL1 under the control of the TRE
1α course
(EF1α)for
promoter,
and
(2) human
B-cell lymphoma
2 (BCL2)
and
miR-9/9*-124
under
thewas added
promoter. factor
(B) Time
induction.
After
the transduction
of miR-9/9*-124
and
ASCL1,
doxycycline
(Dox)
control
of
the
tetracycline
response
element
(TRE)
promoter.
Right:
Lentiviral
vector
containing
to start induction. At post induction day (PID) 4, the cells were re-plated on dishes with neuronal cell-optimized coating.
ASCL1
under
control
of the
TRE promoter.
(B) Time course
forsmall
induction.
Afterthat
theenhance
transduction
The culture
medium
wasthe
replaced
with
neuronal
medium supplemented
with
molecules
reprogramming
at PID 5. The cells were analyzed within ~2 weeks. (C) Morphological changes of neuron-like cells from embryonic and
adult fibroblasts during the induction process. The cells retained fibroblast morphology until re-plating at PID 4. After
re-plating and neuronal medium change, these cells acquired neuron-like morphology. Spherical cell bodies and neurite-like
structures were observed in these cells. Scale bars, 50 µm.

3.3. Neuron-Like Cells from Embryonic and Adult Fibroblasts Show Neural Activity
To evaluate the neuronal functionality of the neuron-like cells, we performed calcium
imaging analysis using the calcium indicator dye Fluo-8 to monitor intracellular calcium
dynamics. Calcium transients were not observed in the induced cells soon after induction
(PID 1); however, after the morphological changes occurred (at approximately PID 10),
we observed spontaneous activity in the neuron-like cells derived from embryonic and
adult fibroblasts (Figure 3A, Supplementary Videos S1 and S2). Interestingly, we observed
synchronized activity among large numbers of neuron-like cells derived from embryonic
fibroblasts, but not in those derived from adult fibroblasts (Figure 3B). This synchronized
activity may have occurred via synaptic interactions, considering the expression of synaptic
markers (Figure 2C–E). In addition, we assessed the neuronal function via drug-induced
modulation, and found that the calcium transients were inhibited by the sodium channel
blocker tetrodotoxin (Figure 3C). Overall, these data showing that the neuron-like cells from
embryonic and adult fibroblasts have neuronal function indicate these cells successfully
differentiated into functional neurons.
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3.3. Neuron-Like Cells from Embryonic and Adult Fibroblasts Show Neural Activity

This synchronized activity may have occurred via synaptic interactions, considering the expression
of synaptic markers (Figure 2C–E). In addition, we assessed the neuronal function via drug-induced
modulation, and found that the calcium transients were inhibited by the sodium channel blocker
tetrodotoxin (Figure 3C). Overall, these data showing that the neuron-like cells from embryonic and
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3.4. Transcriptomic Analysis of Neuron-Like Cells
To analyze the global gene expression profiles of the neuron-like cells, we performed
RNA-seq and compared the profiles between the original fibroblasts and neuron-like cells.
Principal component analysis indicated segregation between the original fibroblasts and
neuron-like cells (Figure 4A). Our gene expression analysis also showed the upregulation of
neuronal marker genes and the downregulation of fibroblast marker genes (Figure 4B). For
instance, the gene expression of pan-neuronal markers such as MAP2, RNA binding fox-1
homolog 3 (RBFOX3), microtubule-associated protein tau (MAPT), and synaptotagmin 1
(SYT1) was upregulated, while the gene expression of fibroblast markers such as collagen
type I alpha 1 chain (COL1A1), collagen type III alpha 1 chain (COL3A1), and vimentin
(VIM) was downregulated in the neuron-like cells. Analysis of the top five gene ontology
terms revealed that the upregulated genes in the neuron-like cells were enriched with
terms related to neuronal differentiation and development, while the downregulated genes
were associated with fibroblast function (Figure 4C). Consistent with the results of the
protein expression levels of SYP and PSD95 between the embryonic and adult neuron-like
cells (Figure 2C–E), the mRNA expression of several synaptic markers was higher in the
embryonic neuron-like cells than in the adult neuron-like cells (Supplementary Figure S3).
Moreover, neuronal subtype-specific gene markers were not upregulated in the neuron-like
cells (Supplementary Figure S4).
We also found that some of the targets of miR-9/9*-124 were regulated in our induction method, e.g., polypyrimidine tract-binding protein 1/2 (PTBP1/2). In somatic
fibroblasts, PTBP1 represses neuronal conversion [31], while PTBP2 accelerates neuronal
conversion [32]. Our gene expression analysis showed the upregulation of PTBP2 and
downregulation of PTBP1 in the neuron-like cells (Figure 4B).
To evaluate further the neuronal transcripts of the neuron-like cells, we performed
quantitative RT-PCR analysis using cDNAs from the original fibroblasts, neuron-like cells,
and marmoset brain tissue. Initially, we quantified the gene expression levels of panneuronal markers, such as TUBB3 (encoding βIII-tubulin), MAP2, RBFOX3, and MAPT.
The results showed the elevation of their gene expression in the neuron-like cells compared
to the original fibroblasts, and their expression levels were comparable with those of
marmoset brain tissue (Figure 4D). In contrast, the expression of the fibroblast marker
gene COL1A1 was significantly decreased in the neuron-like cells compared to the original
fibroblasts (Figure 4E), and was barely detectable in marmoset brain tissue. These results
indicate that the neuronal induction of fibroblasts by miR-9/9*-124 and ASCL1 leads to an
increase in the expression of several neuronal marker genes and a decrease in the expression
of fibroblast marker genes.
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4. Discussion
Although we previously reported a direct neuronal induction method for embryonic
marmoset fibroblasts, the induction of neuronal cells using fibroblasts derived from postnatal marmosets was not achieved [15]. Here, we established a rapid, efficient, and robust
method for direct neuronal conversion, which is applicable to somatic fibroblasts derived
from embryonic and adult marmosets. We used a previously reported method based on
microRNAs (miR-9/9*-124) and a transcription factor (ASCL1), which directly convert
human fibroblasts into neurons. We demonstrated that the combination of these factors
can also induce neuron-like cells from marmoset fibroblasts with high efficiency (about
80%, Figure 2B). The resultant neuron-like cells showed typical features of neurons, such
as neuron-like morphology and the expression of neuronal proteins and mRNAs (Figure 1,
Figure 2, and Figure 4). Moreover, calcium imaging revealed that the neuron-like cells had
the functional properties of neurons (Figure 3). Therefore, these results indicate that the
generated neuron-like cells can be defined as marmoset iNs according to the previously
reported criteria for defining iNs [33].
Although this newly established marmoset iN method showed a high induction
efficiency in adult and embryonic marmoset fibroblasts, some results revealed differences
between adult and embryonic iNs. For example, synaptic markers, such as SYP and PSD95,
were frequently expressed in the embryonic iNs compared to the adult iNs (Figure 2C–E,
Supplementary Table S3). These results suggest that embryonic iNs more closely resemble
mature neurons than adult iNs, possibly related to previous reports that young-derived
cells can be easily reprogrammed at a high efficiency [34]. Considering the negative effect
of aging, collecting fibroblasts at a young age is best suited to obtain iNs that are more
similar to neurons in brain. However, the fact that the present method enables iN induction
from not only embryonic fibroblast but also adult fibroblast extends its usefulness.
Interestingly, we observed synchronized neuronal activity in the embryonic iNs, but
not in the adult iNs (Figure 3B). Synaptic interactions are the common mechanism of
neural communication during neuronal synchronization. In our study, the embryonic iNs
expressed several synaptic markers at a higher level than the adult iNs (Supplementary
Figure S3). Moreover, pre- and postsynaptic marker-positive puncta were partly colocalized
in the embryonic iNs (Figure 2D), possibly indicating the formation of synapses. These
results suggest the contribution of the synaptic interactions to the synchronized activity
observed in the embryonic iNs.
In conclusion, this iN method is broadly applicable for phenotype analysis of disease model marmosets and phenotypic screening to predict the disease severity of presymptomatic animals. The embryonic iN is useful for evaluating synaptic dysfunction
related to neurodegenerative diseases. Meanwhile, the adult iN method provides neuronlike cells minimally invasively without skin biopsy at the fetal stage, albeit with limitations
in the synapse formation. The obtained iNs also allow for the evaluation of neurological
dysfunctions related to Parkinson’s disease, as has been reported previously [35,36]. The iN
method established in the current study should facilitate progress on neurological disease
modeling in non-human primate species.
Supplementary Materials: The following are available online at https://www.mdpi.com/2073-440
9/10/1/6/s1, Figure S1: Efficiency of transgene induction in fibroblasts, Figure S2: Immunocytochemistry of neuron-like cells and fibroblasts, Figure S3: Transcriptomic analysis of synaptic markers,
Figure S4: Transcriptomic analysis of subtype-specific markers, Table S1: Marmoset fibroblasts used
in this study, Table S2: Primer List, Table S3: Summary of this study, Video S1: Calcium imaging
analysis of embryonic neuron-like cells, Video S2: Calcium imaging analysis of adult neuron-like cells.
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